PAVmed Past Earnings Performance
Past criteria checks 0/6
PAVmed's earnings have been declining at an average annual rate of -32.9%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 77.9% per year.
Key information
-32.9%
Earnings growth rate
-3.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 77.9% |
| Return on equity | n/a |
| Net Margin | -2,702.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%?
Jan 29
Is PAVmed (NASDAQ:PAVM) Using Debt In A Risky Way?
Aug 17PAVmed Non-GAAP EPS of -$0.17 beats by $0.03
Aug 16PAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term Progress
Jul 05Start Accumulating PAVmed
Dec 24We Think PAVmed (NASDAQ:PAVM) Can Afford To Drive Business Growth
Sep 02PAVmed: Long Term Investment Case Remains Despite Weak Q2
Aug 23PAVmed: A True Game-Changer For Medical Device Innovation
Jun 14PAVmed forms digital health company, Veris Health
Jun 02PAVmed's subsidiary receives CE mark for EsoCheck esophageal cell collection device
May 26PAVmed (NASDAQ:PAVM) Is In A Good Position To Deliver On Growth Plans
May 19PAVmed drops 14% on launch of $13.4M direct offering
Jan 06PAVmed closes additional direct offering of common stock
Dec 22Do Institutions Own PAVmed Inc. (NASDAQ:PAVM) Shares?
Dec 16PAVmed offers stock for $8.9M
Dec 11PAVmed EPS beats by $0.02
Nov 17There Is Progress At PAVmed, But More Patience Is Required
Oct 30Revenue & Expenses BreakdownBeta
How PAVmed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | -66 | 49 | 14 |
| 30 Sep 23 | 2 | -71 | 52 | 18 |
| 30 Jun 23 | 1 | -79 | 56 | 21 |
| 31 Mar 23 | 1 | -90 | 62 | 24 |
| 31 Dec 22 | 0 | -89 | 61 | 25 |
| 30 Sep 22 | 1 | -86 | 57 | 26 |
| 30 Jun 22 | 1 | -72 | 50 | 25 |
| 31 Mar 22 | 1 | -58 | 43 | 22 |
| 31 Dec 21 | 1 | -51 | 34 | 20 |
| 30 Sep 21 | 0 | -42 | 26 | 17 |
| 30 Jun 21 | 0 | -35 | 20 | 14 |
| 31 Mar 21 | 0 | -30 | 15 | 12 |
| 31 Dec 20 | 0 | -35 | 12 | 11 |
| 30 Sep 20 | 0 | -32 | 11 | 10 |
| 30 Jun 20 | 0 | -30 | 10 | 8 |
| 31 Mar 20 | 0 | -28 | 9 | 8 |
| 31 Dec 19 | 0 | -17 | 8 | 7 |
| 30 Sep 19 | 0 | -17 | 7 | 6 |
| 30 Jun 19 | 0 | -17 | 7 | 5 |
| 31 Mar 19 | 0 | -19 | 7 | 5 |
| 31 Dec 18 | 0 | -19 | 6 | 4 |
| 30 Sep 18 | 0 | -12 | 6 | 3 |
| 30 Jun 18 | 0 | -14 | 6 | 3 |
| 31 Mar 18 | 0 | -10 | 5 | 3 |
| 31 Dec 17 | 0 | -10 | 5 | 3 |
| 30 Sep 17 | 0 | -12 | 5 | 3 |
| 30 Jun 17 | 0 | -9 | 5 | 3 |
| 31 Mar 17 | 0 | -9 | 5 | 2 |
| 31 Dec 16 | 0 | -6 | 4 | 2 |
| 30 Sep 16 | 0 | -5 | 4 | 1 |
| 30 Jun 16 | 0 | -3 | 3 | 1 |
| 31 Mar 16 | 0 | -2 | 2 | 1 |
| 31 Dec 15 | 0 | -2 | 1 | 0 |
Quality Earnings: PAVM is currently unprofitable.
Growing Profit Margin: PAVM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PAVM is unprofitable, and losses have increased over the past 5 years at a rate of 32.9% per year.
Accelerating Growth: Unable to compare PAVM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PAVM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: PAVM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.